Gene · 7322
Papers1,418
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,418
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Computational Identification of RNF114 nsSNPs with Potential Roles in Psoriasis and Immune Dysregulation. | Med Sci (Basel) | 2025 | 40981192 | PubTator, text mining | PubMed |
| STK4 inhibits the E3 activity of HOIP by phosphorylating its allosteric ubiquitin-binding site. | Cell Discov | 2025 | 40957900 | PubTator, text mining | PubMed |
| From COPD to Smoke-Related Arteriopathy: The Mechanical and Immune-Inflammatory Landscape Underlying Lung Cancer Distant Spreading-A Narrative Review. | Cells | 2025 | 40862704 | PubTator, text mining | PubMed |
| Phospholipid scramblase 1 (PLSCR1) is a novel substrate of NEDD4-2 (NEDD4L) mediated ubiquitination. | Cell Death Discov | 2025 | 40835608 | PubTator, text mining | PubMed |
| Molecular Mechanisms of Cadmium-Induced Toxicity and Its Modification. | Int J Mol Sci | 2025 | 40806643 | PubTator, text mining | PubMed |
| Multi-omics identification of circulating protein biomarkers for intervertebral disc degeneration using Mendelian randomization and scRNA-seq. | Clin Rheumatol | 2025 | 40745068 | PubTator, text mining | PubMed |
| The P132H mutation of SARS-CoV-2 NSP5 relieves its inhibition on interferon-β activation via blocking MAVS degradation. | Cell Mol Life Sci | 2025 | 40736574 | PubTator, text mining | PubMed |
| Selection of Stable Reference Genes for Gene Expression Studies in Activated and Non-Activated PBMCs Under Normoxic and Hypoxic Conditions. | Int J Mol Sci | 2025 | 40725038 | PubTator, text mining | PubMed |
| Lycorine hydrochloride directly targets UBA1 to suppress cellular senescence. | Acta Pharm Sin B | 2025 | 40370534 | PubTator, text mining | PubMed |
| Identification of RING E3 pseudoligases in the TRIM protein family. | Nat Commun | 2025 | 40216791 | PubTator, text mining | PubMed |
| The ubiquitin-conjugating enzyme UBE2D maintains a youthful proteome and ensures protein quality control during aging by sustaining proteasome activity. | PLoS Biol | 2025 | 39879147 | PubTator, text mining | PubMed |
| Molecular characterization of the E2 conjugating enzyme LinfUbc13 in Leishmania infantum. | Arch Biochem Biophys | 2025 | 39689751 | PubTator, text mining | PubMed |
| Bioinformatics-Based Construction of Immune-Related microRNA and mRNA Prognostic Models for Hepatocellular Carcinoma. | Cancer Manag Res | 2024 | 39741650 | PubTator, text mining | PubMed |
| Plastid translocon recycling in dinoflagellates demonstrates the portability of complex plastids between hosts. | Curr Biol | 2024 | 39571577 | PubTator, text mining | PubMed |
| Engineering the orthogonal ubiquitin E1-E2 pairs for identification of K27 chain linkage substrates. | Int J Biol Macromol | 2024 | 39566774 | PubTator, text mining | PubMed |
| Targeting the HECTD3-p62 axis increases the radiosensitivity of triple negative breast cancer cells. | Cell Death Discov | 2024 | 39487119 | PubTator, text mining | PubMed |
| Structural and biophysical characterisation of ubiquitin variants that inhibit the ubiquitin conjugating enzyme Ube2d2. | FEBS J | 2024 | 39473070 | PubTator, text mining | PubMed |
| Copper metabolism-related signature for prognosis prediction and MMP13 served as malignant factor for breast cancer. | Heliyon | 2024 | 39315182 | PubTator, text mining | PubMed |
| Exploration of the ubiquitination-related molecular classification and signature to predict the survival and immune microenvironment in colon cancer. | Front Genet | 2024 | 39268080 | PubTator, text mining | PubMed |
| Unraveling the role of ubiquitin-conjugating enzyme 5 (UBC5) in disease pathogenesis: A comprehensive review. | Cell Signal | 2024 | 39236836 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7322/papers?page=2